The laws of attraction: Chemokines, neutrophils and eosinophils in severe exacerbations of asthma

Thorax

Volumn 62, Issue 6, 2007, Pages 465-466

  Turato, Graziella ^a   Baraldo, Simonetta ^a   Zuin, Renzo ^a   Saetta, Marina ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHEMOKINE; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CORTICOSTEROID; EOTAXIN; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ASTHMA; AUTOPSY; BRONCHUS BIOPSY; CD4+ T LYMPHOCYTE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DRUG MEGADOSE; EDITORIAL; EOSINOPHIL; HEALTH CARE SYSTEM; HUMAN; INFLAMMATION; LUNG FUNCTION; LUNG LAVAGE; MAST CELL; MORTALITY; NEUTROPHIL; PRIORITY JOURNAL; RESPIRATORY FAILURE; THORAX;

ASTHMA; CHEMOKINES; EOSINOPHILS; HUMANS; NEUTROPHILS; RECEPTORS, CHEMOKINE;

EID: 34250334568     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2006.070656     Document Type: Editorial

References (22)

1. Masoli M, Fabian D, Holt S, et al. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004;59:469-78.
2. Johnston NW, Sears MR. Asthma exacerbations - 1: Epidemiology. Thorax 2006;61:722-8.
3. Barbato A, Turato G, Baraldo S, et al. Airway inflammation in childhood asmma. Am J Respir Crit Care Med 2003;168:798-803.
4. Fabbri LM, Romagnoli M, Corbetta L, et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:418-24.
5. Jeffery PK, Remodeling and inflammation of bronchi in asthma ana chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004;1:176-83.
6. Qiu Y, Zhu J, Bandi V, et al. Bronchial mucosal inflammation and upregulation of CXC chemoattractants and receptors in severe exacerbations of asthma. Thorax 2007;62:475-82.
7. Fahy JV, Kim KW, Liu J, et al. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 1995;95:843-52.
8. Lamblin C, Gosset C, Tillie-LeBlond I, et al. Bronchial neutrophilia in patients with non-infectious status asthmaticus. Am J Respir Crit Care Med 1998;157:394-402.
9. Wark PAB, Gibson PG. Asthma exacerbations - 3: Pathogenesis. Thorax 2006;61:909-15.
10. Sur S, Crotty TB, Kephart GM, et al. Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis 1993;148:713-9.
11. Carroll N, Carello S, Cooke C, et al. Airway structure and inflammatory cells in fatal attacks of asthma. Eur Respir J 1996;9:709-15.
12. Qiu Y, Zhu J, Bandi V, et al. Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;168:968-75.
13. Ahuja SK, Murphy PM. The CXC chemokine growth-regulated oncogene (GRO)α, (GRO)β, (GRO)γ, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J Biol Chem 1996;271:20545-50.
14. Persson T, Monsef N, Andersson P, et al. Expression of the neutrophil-activating CXC chemokine EXA78/CXCL5 by human eosinophils. Clin Exp Allergy 2003;33:531-7.
15. Howarth PH, Babu KS, Arshad HS, et al. Tumour necrosis factor α (TNFα) as a novel therapeutic target in symptomatic corticosteroid-dependent asthma. Thorax 2005;60:1012-8.
16. Berry MA, Hargadon B, Shelley M, et al. Evidence of a role of tumour necrosis factor α in refractory asthma. N Engl J Med 2006;354:697-708.
17. Tillie-LeBlond I, Pugin J, Marquette CH, et al. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am J Respir Crit Care Med 1999;159:487-94.
18. Erin EM, Leaker BR, Nicholson GC, et al. The effects of a monoclonal antibody directed against tumour necrosis factor α in asthma. Am J Respir Crit Care Med 2006;174:753-62.
19. Holgate ST, Polosa R. The mechanisms, diagnosis and management of severe asthma in adults. Lancet 2006;368:780-93.
20. Martin TR. Neutrophils and lung injury: getting it right. J Clin Invest 2002;110:1603-5.
21. Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J Immunol 1995;154:4719-25.
22. Wenzel SE, Szefler SJ, Leung DYM, et al. Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 1997;156:737-43.